Reversal Options in Direct Oral Anticoagulant Therapies

Update: 2022-04-12

Description

In this episode, Dr. Miller will discuss the current treatment options in the reversal of several classes of DOAC medications.

Comments

In Channel

Transfusion-transmitted babesiosis

2024-02-0617:12

The Donor Center Perspective on the Work Up for Transfusion Reactions

2023-12-2940:53

Patient blood management with MaryAnn Sromoski

2023-06-3013:12

Lecture Series: Heparin-like molecule causing coagulopathy in a patient with recent liver transplant

2023-03-2706:26

Lecture series: RhD variants

2023-03-0905:22

Lecture series: A case report and review of cold agglutinin disease

2023-02-2305:58

Lecture Series: Part 1: Transfusion Reactions

2023-12-2620:09

Career Series: Interview with an Apheresis Nurse

2022-06-3014:26

Implementation of a Bloodless Surgery Program

2022-05-1204:50

Reversal Options in Direct Oral Anticoagulant Therapies

2022-04-1207:05

Interview with Past BBANYS president, Mark Friedman, DO

2021-08-2009:30

Lecture Series: Neonatal Transfusion in HDFN and FNAIT

2021-06-2326:00

Dialogue Series: Transfusion Associated Circulatory Overload

2021-05-2209:02

Career series: Cellular Therapy Laboratory Manager

2021-04-3030:27

Dialogue Series: Molecular Testing in Immunohematology

2021-03-2712:23

Career Series: Blood Bank Manager

2021-02-2817:58

Lecture Series: Sickle Cell Disease Basics

2021-01-2513:27

Lecture Series: Transfusion Support for Hematopoietic Stem Cell Transplantation

2020-11-0412:01

Dialogue Series: Transfusion Reactions

2020-11-0410:39

Utilization of Fibrinogen Concentrate versus Cryoprecipitate

2022-01-0306:03

00:00

1.0x

Reversal Options in Direct Oral Anticoagulant Therapies

#box-pro-ellipsis-175892038211370{-webkit-line-clamp:2;}Reversal Options in Direct Oral Anticoagulant Therapies

Reversal Options in Direct Oral Anticoagulant Therapies

BBANYS

Reversal Options in Direct Oral Anticoagulant Therapies